Bipolar disorder treatment for Boca Raton — the diagnosis primary care misses.

From Mizner Park or Royal Palm Place, RECO Integrated Psychiatry's Delray Beach office is 20 minutes up Federal Highway — close enough that specialist bipolar care fits into a working week without relocation. The practice runs lithium the way it should be run: baseline TSH, creatinine, calcium, CBC, quarterly serum levels titrated to 0.6-1.0 mEq/L, and ongoing renal and thyroid monitoring. Diagnosis is treated as load-bearing, because misreading bipolar depression as unipolar is the most common reason patients spend years on the wrong medications.

From Mizner Park or Royal Palm Place, the drive up Federal Highway to RECO Integrated Psychiatry’s Delray Beach office is about 20 minutes — shorter than most Boca Raton morning commutes, and short enough that specialist psychiatric care fits inside a working week rather than requiring a leave of absence. For adults with bipolar disorder, that geography matters: the condition is chronic, the medications require monitoring on a schedule, and the treatment relationship works best when appointments are logistically boring. Our bipolar disorder treatment program is built for outpatient continuity — mood stabilizer optimization, structured level and metabolic monitoring, and coordination with therapy modalities that have actual bipolar-specific evidence.

Bipolar I versus bipolar II versus bipolar spectrum

The distinction is not academic. Bipolar I requires at least one manic episode — seven days of elevated or irritable mood with functional impairment, hospitalization, or psychosis. Bipolar II requires a hypomanic episode (four days, no functional collapse) plus a major depressive episode. Bipolar spectrum captures presentations that do not fit either box cleanly: cyclothymia, BP-NOS, antidepressant-induced hypomania, and subthreshold cyclicity that nevertheless drives clinical impairment.

The pharmacology diverges by diagnosis. Bipolar I typically benefits from a mood stabilizer plus a second-generation antipsychotic, with lithium or valproate carrying most of the load. Bipolar II depression responds well to lamotrigine and quetiapine but does not respond to lithium as reliably as bipolar I does, and it is disproportionately harmed by unopposed antidepressants. Bipolar spectrum presentations require the most judgment — antidepressants can be used, but only with mood stabilizer cover and a clear plan for what a switch looks like.

RECO’s evaluation uses the MDQ and HCL-32 as screens, structured hypomania history with a collateral informant when the client consents, and mood charting across a two-to-four-week baseline. Misdiagnosis of bipolar depression as unipolar depression is the single most common reason patients spend years on medications that do not work; getting the diagnosis right is the load-bearing piece of the treatment plan.

Lithium: the treatment we take seriously when others do not

Lithium is still the most effective long-term mood stabilizer in bipolar disorder and the only psychiatric medication with replicated evidence for reducing suicide. It is also the medication that primary care and general psychiatry avoid most often, usually because of the monitoring burden rather than any specific tolerability problem.

The protocol is straightforward: baseline TSH, creatinine, calcium, and CBC before starting; titration to a maintenance level of 0.6-1.0 mEq/L (higher for acute mania, lower for maintenance in older adults); levels drawn 12 hours post-dose, quarterly for the first year, then twice yearly; and ongoing surveillance for weight gain, thyroid dysfunction, tremor, and renal function. Interactions with NSAIDs, ACE inhibitors, and thiazide diuretics are actively managed.

For patients who tolerate lithium, the long-term outcome data justifies the monitoring. For patients who do not, the practice moves on rather than white-knuckling a doomed trial. Either way, the decision is made on data, not on which medication is easiest to prescribe.

Second-generation antipsychotics and where they fit

Several second-generation antipsychotics carry FDA approval for specific bipolar indications, and phase drives the choice. Quetiapine is approved across bipolar depression, mania, and maintenance and is often first-line for bipolar II depression. Lurasidone is approved for bipolar depression with a comparatively favorable metabolic profile. Aripiprazole and cariprazine cover mania and maintenance. Olanzapine and olanzapine-fluoxetine combination are effective for bipolar depression and mania but carry the heaviest metabolic burden. Risperidone is used for acute mania.

Metabolic monitoring is standard: weight and BMI at every visit, fasting glucose or HbA1c and lipid panel at baseline and at least annually, and blood pressure at each visit. Prolactin is checked when clinically indicated. Extrapyramidal symptoms and akathisia are screened for actively — akathisia in particular is often mistaken for worsening mood, and the wrong response can escalate the wrong medication.

Choice is driven by phase, tolerability profile, prior response, and whether the patient’s primary problem is depression, mania prevention, or maintenance. There is no single correct antipsychotic in bipolar disorder; there is a correct match between drug and clinical picture.

Lamotrigine, valproate, and the anticonvulsant options

Lamotrigine has the strongest evidence for bipolar II depression and for maintenance treatment when depression is the predominant pole. Titration is slow by protocol — 25 mg daily for two weeks, 50 mg for two weeks, 100 mg for one week, then 200 mg — because rapid escalation raises the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis. Any rash in the first eight weeks stops the medication. Concurrent valproate or oral contraceptives shift the target dose because of enzyme interactions.

Valproate is effective for acute mania and mixed states and is often the pragmatic choice when lithium is contraindicated. Monitoring includes LFTs, platelets, and serum levels targeted to 50-125 mcg/mL, with pregnancy testing and contraceptive counseling in patients of reproductive potential — the teratogenic and neurodevelopmental risks are significant enough that valproate is not a first choice in that population.

Carbamazepine and oxcarbazepine are second-line options with their own monitoring requirements (sodium, CBC, drug interactions via CYP3A4 induction). RECO’s practice runs each of these medications rather than defaulting to whichever is easiest, and the choice is made against the clinical picture rather than the prescriber’s comfort.

What to expect on your first visit

The initial evaluation is 60-90 minutes with a psychiatric provider. It covers current symptoms, past episodes and hospitalizations, prior medication trials with dose and duration, family psychiatric history, medical comorbidities, substance use, and functional history at work and in relationships. Structured screeners — PHQ-9, GAD-7, MDQ, HCL-32, and ASRS where indicated — are used to anchor severity. If bipolar is suspected but not confirmed, the plan may be to hold major medication changes until a two-to-four-week mood chart is complete.

Labs typically ordered include TSH, CMP, CBC, HbA1c, lipid panel, and vitamin D, with additional testing based on the medications under consideration. Follow-up cadence is weekly to biweekly during titration, monthly once stable, and quarterly for level checks on lithium or valproate. Coordination with an outside therapist is standard — modalities with the strongest bipolar-specific evidence are interpersonal and social rhythm therapy, family-focused therapy, and CBT adapted for bipolar disorder.

Insurance and admissions from Boca Raton

RECO Integrated Psychiatry works with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. Benefits are verified before the first appointment, with copay, remaining deductible, and any prior authorization requirements confirmed in writing. Boca Raton residents from Downtown Boca, Boca West, and Highland Beach reach the Delray Beach office in about 20 minutes via Federal Highway or I-95; telepsychiatry is available for follow-up visits where clinically appropriate, which for most stable bipolar maintenance patients translates to one in-person visit per quarter with telehealth in between.

Serving residents of: Mizner Park, Royal Palm Place, Downtown Boca, Boca West, Highland Beach.